Posts by cstephenson@legacymedsearch.com
Executive Tenure at the Top: What MedTech Boards Should Be Aware Of
By Chris Miclot, Partner & General Manager | Legacy MEDSearch Over the past two decades of placing executive leadership across MedTech, I’ve watched boards spend enormous energy debating compensation packages and search timelines, while underinvesting in the harder question: why do CEOs actually leave, and what could have kept them? The data tells a clear story. In 2025,…
Read MoreThe Next Frontier in Neurosurgery: What (MedTech) Leaders Need to Know
The Next Frontier in Neurosurgery: What MedTech Executives Need to Know By Chris Miclot, Partner & General Manager | Legacy MEDSearch Published on LinkedIn | Reflecting on observations from AANS Annual Meeting What used to live in research abstracts and speculative panels is now being demonstrated in operating rooms. After the American Association of Neurological…
Read More10-Person Legacy MEDSearch Named to Forbes America’s Best Executive / Professional Recruiting Firms for the Tenth Time
Exclusive MedTech Firm Among the Top 175 of 22,000+ US Recruiting Firms. Orlando, FL — June 9, 2026 — For the tenth time since first appearing in 2019, Legacy MEDSearch has been named to Forbes America’s Best Executive and Professional Recruiting Firms, presented by Forbes and Statista. Legacy MEDSearch separates itself from virtually every firm…
Read MoreThe Ripple Effect: How Recent U.S. Tariffs Will Impact Medical Device Sales and Manufacturing in 2025
The medical device industry has long been a globalized ecosystem, with raw materials, components, and finished products crisscrossing international supply chains before reaching healthcare providers. However, the latest wave of U.S. tariffs—targeting imports from key manufacturing hubs like China, Mexico, and Canada—is set to introduce new challenges that will reshape the landscape of medical device…
Read MoreWhat is the Difference Between MedTech and TechMed?
I love working in the medical industry, watching its evolution and emerging trends. Just as job titles have grown over the years to include Innovation Officers, VP People and Culture, Head of Digital Strategy and more there are terms coming into common parlance. Since we work with early-stage companies, I thought I would share a…
Read MoreFDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
On March 5, the U.S. Food and Drug Administration (FDA) announced the clearance of Dexcom’s device, marking it as the first continuous glucose monitor available over the counter. Following this announcement, Dexcom’s shares experienced a 2.2% increase in extended trading. Known as Stelo, this device is tailored for individuals aged 18 and older who do…
Read MoreFDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Boston Scientific’s AGENT™ Drug-Coated Balloon (DCB) has been granted approval by the U.S. Food and Drug Administration (FDA) for treating coronary in-stent restenosis (ISR) in patients with coronary artery disease. While advancements in percutaneous coronary intervention (PCI) technologies are ongoing, recent research indicates that ISR, the gradual re-narrowing of a previously opened coronary artery, still…
Read MoreSparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope
Sparrow BioAcoustics recently unveiled its StethophoneTM software, which transforms smartphones into medical-grade stethoscopes. This innovative tool enables users to capture, analyze, and share crucial heart health data with medical professionals from any location. In June 2023, Sparrow received FDA clearance for the downloadable application, making it the first FDA-cleared smartphone stethoscope software-as-a-medical-device (SaMD). The company…
Read MoreBrainomix and Nanoflex Robotics to Collaborate on an AI-Assisted Robotic System for Remote Stroke Intervention
Brainomix Ltd, an AI-powered medtech solutions company, and Nanoflex Robotics AG, a remote robotic surgical company based in Switzerland, have been awarded a grant under the “UK – Switzerland Bilateral: Collaborative R&D” program, in which the companies will work together to jointly develop an integrated remote diagnosis and treatment platform for stroke, powered by artificial intelligence.…
Read MoreFDA clears Intelivation Technologies new Hammerdesis™ Interphalangeal Fusion System
Intelivation Technologies, an innovative medical device company with a cutting-edge orthopedic portfolio announced today that it has received clearance from the Food and Drug Administration for its Hammerdesis™ Interphalangeal Fusion System. Hammerdesis™ allows surgeons to correct hammertoe deformities and degenerative issues in patients by simply affixing a distinctively designed implant on the patient’s toe joint. This one-of-a-kind…
Read More